A detailed history of Cubist Systematic Strategies, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 241,686 shares of GILD stock, worth $21.3 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
241,686
Previous 241,686 -0.0%
Holding current value
$21.3 Million
Previous $16.6 Million -0.0%
% of portfolio
0.12%
Previous 0.12%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$63.15 - $72.88 $555,783 - $641,416
-8,801 Reduced 3.51%
241,686 $16.6 Million
Q1 2024

May 15, 2024

BUY
$71.58 - $87.29 $12.8 Million - $15.7 Million
179,417 Added 252.45%
250,487 $18.3 Million
Q4 2023

Feb 14, 2024

BUY
$73.27 - $83.09 $4.52 Million - $5.13 Million
61,722 Added 660.27%
71,070 $5.76 Million
Q3 2023

Nov 14, 2023

BUY
$73.94 - $80.67 $691,191 - $754,103
9,348 New
9,348 $700,000
Q1 2023

May 15, 2023

SELL
$77.31 - $88.08 $20.2 Million - $23.1 Million
-261,714 Reduced 54.24%
220,831 $18.3 Million
Q4 2022

Feb 14, 2023

SELL
$62.32 - $89.47 $3.7 Million - $5.31 Million
-59,335 Reduced 10.95%
482,545 $41.4 Million
Q3 2022

Nov 14, 2022

BUY
$59.54 - $68.01 $15.8 Million - $18.1 Million
265,585 Added 96.12%
541,880 $33.4 Million
Q2 2022

Aug 15, 2022

SELL
$57.72 - $65.01 $11.4 Million - $12.9 Million
-197,953 Reduced 41.74%
276,295 $17.1 Million
Q1 2022

May 16, 2022

BUY
$57.92 - $72.58 $20.2 Million - $25.4 Million
349,488 Added 280.13%
474,248 $28.2 Million
Q4 2021

Feb 14, 2022

BUY
$64.88 - $73.64 $3.12 Million - $3.55 Million
48,154 Added 62.86%
124,760 $9.06 Million
Q3 2021

Nov 15, 2021

SELL
$67.69 - $73.03 $3.74 Million - $4.04 Million
-55,320 Reduced 41.93%
76,606 $5.35 Million
Q2 2021

Aug 16, 2021

BUY
$63.47 - $69.35 $223,414 - $244,111
3,520 Added 2.74%
131,926 $9.08 Million
Q1 2021

May 17, 2021

BUY
$60.0 - $68.46 $393,120 - $448,549
6,552 Added 5.38%
128,406 $8.3 Million
Q4 2020

Feb 16, 2021

BUY
$56.65 - $64.55 $2.31 Million - $2.64 Million
40,856 Added 50.44%
121,854 $7.1 Million
Q3 2020

Nov 16, 2020

BUY
$62.1 - $78.08 $3.95 Million - $4.96 Million
63,588 Added 365.24%
80,998 $5.12 Million
Q2 2020

Aug 14, 2020

SELL
$72.34 - $84.0 $2.03 Million - $2.36 Million
-28,056 Reduced 61.71%
17,410 $1.34 Million
Q1 2020

May 15, 2020

SELL
$62.63 - $80.22 $2.62 Million - $3.35 Million
-41,816 Reduced 47.91%
45,466 $3.4 Million
Q4 2019

Feb 14, 2020

SELL
$61.62 - $67.78 $7.29 Million - $8.02 Million
-118,383 Reduced 57.56%
87,282 $5.67 Million
Q3 2019

Nov 14, 2019

SELL
$62.51 - $69.0 $2.21 Million - $2.44 Million
-35,292 Reduced 14.65%
205,665 $13 Million
Q2 2019

Aug 14, 2019

BUY
$61.87 - $69.38 $11.3 Million - $12.7 Million
182,921 Added 315.19%
240,957 $16.3 Million
Q1 2019

May 15, 2019

SELL
$62.53 - $70.05 $4.91 Million - $5.5 Million
-78,500 Reduced 57.49%
58,036 $3.77 Million
Q4 2018

Feb 14, 2019

BUY
$60.54 - $79.0 $7.54 Million - $9.85 Million
124,627 Added 1046.49%
136,536 $8.54 Million
Q3 2018

Nov 14, 2018

SELL
$71.28 - $78.92 $332,164 - $367,767
-4,660 Reduced 28.12%
11,909 $919,000
Q2 2018

Aug 14, 2018

SELL
$64.88 - $75.68 $41,912 - $48,889
-646 Reduced 3.75%
16,569 $1.17 Million
Q1 2018

May 15, 2018

BUY
$72.84 - $88.8 $643,759 - $784,814
8,838 Added 105.5%
17,215 $1.3 Million
Q4 2017

Feb 14, 2018

SELL
$71.15 - $83.52 $1.04 Million - $1.22 Million
-14,589 Reduced 63.52%
8,377 $600,000
Q3 2017

Nov 14, 2017

BUY
$72.11 - $85.47 $1.66 Million - $1.96 Million
22,966
22,966 $1.86 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $110B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Cubist Systematic Strategies, LLC Portfolio

Follow Cubist Systematic Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.